Close Concerns Revenue and Competitors

In 2002, 18.2 million Americans had diabetes, the annual revenue of all diabetes-related companies totaled $14 billion, and Kelly Close founded Close Concerns as a one-person consultancy. Since then, diabetes has become a worldwide epidemic, the industry has expanded to over $40 billion, and Close Concerns has grown in size and scope to become a leading information source on the business of diabetes and obesity. Close Concerns' mission is to improve patient outcomes by making researchers, clinicians, scientists, companies, patients, and families smarter about diabetes and obesity. We do this by creating and synthesizing news and insights on therapies and technologies related to these conditions. Our information services, Diabetes Close Up and Closer Look, keep researchers and members of industry abreast of scientific breakthroughs and market dynamics. We helped launch diaTribe, an education resource which informs patients and caregivers of the latest products and research in diabetes, and now runs under The diaTribe Foundation, an independent non-profit organization. And through a partnership with our sister company, dQ&A, we offer corporate clients an array of market research and consulting services. We study new research relentlessly and interview dozens of clinicians and thought leaders annually. We are advocates for better education, access to innovative therapies, and a healthcare system that encourages providers to give personal care to every individual who has or is at risk of developing diabetes or who is obese. Finally, through our associate program, we develop future leaders in medicine and research, who we hope will teach others about these major public health concerns.